Table 3.
Length of stay, therapies, and qualitative variables.
| Alive (n=12) | Nonsurvivors (n=47) | Total (n=59) | |
|---|---|---|---|
| LOS (days), median (interquartile range) | 4 (3–7) | 4 (3–8) | 4 (3–7) |
| IMV, n (%) | 13 (27.7)∗ | 10 (83.3)∗ | 23 (39.0) |
| Mobility, n (%) | 47 (100)∗ | 8 (66.7)∗ | 55 (93.2) |
| Sedation, n (%) | 15 (31.9)∗ | 10 (83.3)∗ | 25 (42.4) |
| Steroids, n (%) | 11 (23.4) | 1 (8.3) | 12 (20.3) |
| Norepinephrine, n (%) | 10 (21.3) | 6 (50.0) | 16 (27.1) |
| Vasopressin, n (%) | 16 (34.0) | 8 (66.7) | 24 (40.7) |
| Insulin, n (%) | 18 (38.3)∗ | 9 (75.0)∗ | 27 (45.8) |
| Hemodialysis, n (%) | 6 (12.8) | 0 (0) | 6 (10.2) |
| High nutritional risk, n (%) | 12 (25.5)∗ | 7 (58.3)∗ | 19 (32.2) |
LOS: length of stay; IMV: invasive mechanical ventilation; high nutritional risk: NUTRIC ≥ 5. ∗p < 0.05 indicates difference between groups.